IRCT20211108052997N1
Recruiting
Phase 3
Evaluation of efficacy and safety of microneedling and phenytoin cream 1% compared to microneedling in atrophic scars caused by facial acne: a double-blind randomized clinical trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Atrophic Scars.
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 25
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with atrophic facial acne scars aged 18\-45 years
- •Patients with skin type 1\-4
Exclusion Criteria
- •Sensitivity to phenytoin.
- •Patients who have received laser treatment in the last three months.
- •Patients with active colloidal scar or active skin lesion at the injection site.
- •History of malignancy or receiving chemotherapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
A study of the efficacy and safety of microneedle patch containing triamcinolone acetonide and hydrocortisone in the treatment of inflammatory acneinflammatory acneTCTR20220830003ational Research Council of Thailand10
Unknown
Phase 4
A pilot study of efficacy and safety of microneedling-assisted topical botulinum toxin A for the treatment of enlarged facial pores: a split-face randomized-controlled pilot studyEnlarged facial poresBotulinum toxinEnlarged poresMicroneedleTCTR20230418007Faculty of Medicine Siriraj Hospital, Mahidol University25
Not yet recruiting
Phase 4
Comparison ofmicroneedling vs microneedling with platelet rich plasma in the treatment of male-pattern hairlossHealth Condition 1: L649- Androgenic alopecia, unspecifiedCTRI/2024/04/065133Government Medical College and Hospital, Chandigarh
Completed
Phase 2
Comparison of microneedling with Tranexamic acid and PRP in treatment of MelasmaIRCT20221025056287N1Ahvaz University of Medical Sciences23
Recruiting
Phase 2
Microneedling with tranexamic acid and also microneedling with vitamin C for the treatment of melasmaIRCT20210608051516N1Ahvaz University of Medical Sciences34